Literature DB >> 26790589

Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma.

Sin Woo Lee1, Hyun Hwan Sung1, Hwang Gyun Jeon1, Byong Chang Jeong1, Seong Soo Jeon1, Hyun Moo Lee1, Han-Yong Choi1, Seong Il Seo2.   

Abstract

OBJECTIVE: To examine radiological growth patterns as an indicator of renal tumor aggressiveness, we studied about the growth kinetics of small renal mass (SRM, ≤4 cm) and possible associated factors for high Fuhrman nuclear grade (≥3).
MATERIALS AND METHODS: From January 1999 to May 2013, 112 cases (111 patients) diagnosed as renal cell carcinoma after surgical treatment were reviewed retrospectively. Patients who had at least two preoperative contrast-enhanced computed tomography scans more than 6 months apart were included.
RESULTS: The mean age was 59 years and mean computed tomography follow-up duration was 20 months. Median tumor size and tumor volume at diagnosis were 1.45 cm and 1.80 cm(3), respectively. Median linear growth rate (LGR) was 0.28 cm/year. Median volumetric growth rate was 0.75 cm(3)/year and median volume doubling time was 1.41 years. Tumor growth rate was not different to histologic type (P = .271). High LGR was a significant factor associated with high Fuhrman grade in multivariate analysis (odds ratio 3.877, 95% confidence interval 1.715-8.765). Volumetric growth rate (P <.001) and volume doubling time (P = .004) were positive correlation with initial mass size, but not LGR (P = .764).
CONCLUSION: In our growth kinetics study, generally small renal mass grew slowly. High LGR could be a risk factor for high-grade tumor (Fuhrman grade ≥3).
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26790589     DOI: 10.1016/j.urology.2015.10.051

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Rare isolated synchronous splenic metastasis in a patient with type II papillary renal cell carcinoma.

Authors:  Zhenbang Liu; Marcus Way Lunn Chow; Alex Hui Chung Lua; Ronny Ban Wei Tan
Journal:  AME Case Rep       Date:  2018-03-14

2.  Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma.

Authors:  Arturo Álvarez-Arenas; Wilfried Souleyreau; Andrea Emanuelli; Lindsay S Cooley; Jean-Christophe Bernhard; Andreas Bikfalvi; Sebastien Benzekry
Journal:  PLoS Comput Biol       Date:  2022-08-25       Impact factor: 4.779

3.  Active Surveillance for Risk Stratification of All Small Renal Masses Lacking Predefined Clinical Criteria for Intervention.

Authors:  Arun R Menon; Ahmed A Hussein; Kristopher M Attwood; Tashionna White; Gaybrielle James; Bo Xu; Michael Petroziello; Charles L Roche; Eric C Kauffman
Journal:  J Urol       Date:  2021-03-29       Impact factor: 7.600

Review 4.  Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy.

Authors:  Hainan Xu; Shutao Tan
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.